BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Goodhand JR, Wahed M, Mawdsley JE, Farmer AD, Aziz Q, Rampton DS. Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors. Inflamm Bowel Dis. 2012;18:2301-2309. [PMID: 22359369 DOI: 10.1002/ibd.22916] [Cited by in Crossref: 127] [Cited by in F6Publishing: 106] [Article Influence: 14.1] [Reference Citation Analysis]
Number Citing Articles
1 Barberio B, Zamani M, Black CJ, Savarino EV, Ford AC. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2021;6:359-70. [PMID: 33721557 DOI: 10.1016/S2468-1253(21)00014-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
2 Moisset X, Bommelaer G, Boube M, Ouchchane L, Goutte M, Dapoigny M, Dallel R, Guttmann A, Clavelou P, Buisson A. Migraine prevalence in inflammatory bowel disease patients: A tertiary-care centre cross-sectional study. Eur J Pain 2017;21:1550-60. [DOI: 10.1002/ejp.1056] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
3 van der Marel S, Majowicz A, Kwikkers K, van Logtenstein R, te Velde AA, De Groot AS, Meijer SL, van Deventer SJ, Petry H, Hommes DW, Ferreira V. Adeno-associated virus mediated delivery of Tregitope 167 ameliorates experimental colitis. World J Gastroenterol 2012;18:4288-99. [PMID: 22969191 DOI: 10.3748/wjg.v18.i32.4288] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
4 Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, Hayee B, Lomer MCE, Parkes GC, Selinger C, Barrett KJ, Davies RJ, Bennett C, Gittens S, Dunlop MG, Faiz O, Fraser A, Garrick V, Johnston PD, Parkes M, Sanderson J, Terry H;  IBD guidelines eDelphi consensus group; Gaya DR, Iqbal TH, Taylor SA, Smith M, Brookes M, Hansen R, Hawthorne AB. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68:s1-s106. [PMID: 31562236 DOI: 10.1136/gutjnl-2019-318484] [Cited by in Crossref: 361] [Cited by in F6Publishing: 255] [Article Influence: 180.5] [Reference Citation Analysis]
5 Ananthakrishnan AN. Environmental risk factors for inflammatory bowel diseases: a review. Dig Dis Sci. 2015;60:290-298. [PMID: 25204669 DOI: 10.1007/s10620-014-3350-9] [Cited by in Crossref: 83] [Cited by in F6Publishing: 68] [Article Influence: 11.9] [Reference Citation Analysis]
6 Bennebroek Evertsz' F, Nieuwkerk PT, Stokkers PC, Ponsioen CY, Bockting CL, Sanderman R, Sprangers MA. The Patient Simple Clinical Colitis Activity Index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: A comparison of the P-SCCAI with clinician-based SCCAI and biological markers. Journal of Crohn's and Colitis 2013;7:890-900. [DOI: 10.1016/j.crohns.2012.11.007] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 6.5] [Reference Citation Analysis]
7 Wynne B, Mchugh L, Gao W, Keegan D, Byrne K, Rowan C, Hartery K, Kirschbaum C, Doherty G, Cullen G, Dooley B, Mulcahy HE. Acceptance and Commitment Therapy Reduces Psychological Stress in Patients With Inflammatory Bowel Diseases. Gastroenterology 2019;156:935-945.e1. [DOI: 10.1053/j.gastro.2018.11.030] [Cited by in Crossref: 41] [Cited by in F6Publishing: 26] [Article Influence: 20.5] [Reference Citation Analysis]
8 Edney JC, Lam H, Raval MV, Heiss KF, Austin TM. Implementation of an enhanced recovery program in pediatric laparoscopic colorectal patients does not worsen analgesia despite reduced perioperative opioids: a retrospective, matched, non-inferiority study. Regional Anesthesia & Pain Medicine 2019;44:123-9. [DOI: 10.1136/rapm-2018-000017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Maconi G, Gridavilla D, Viganò C, Sciurti R, Asthana AK, Furfaro F, Re F, Ardizzone S, Ba G. Perianal disease is associated with psychiatric co-morbidity in Crohn's disease in remission. Int J Colorectal Dis 2014;29:1285-90. [PMID: 24986138 DOI: 10.1007/s00384-014-1935-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
10 Kennedy PJ, Clarke G, O‘Neill A, Groeger JA, Quigley EMM, Shanahan F, Cryan JF, Dinan TG. Cognitive performance in irritable bowel syndrome: evidence of a stress-related impairment in visuospatial memory. Psycholog Med. 2013;FirstView:1-14. [PMID: 23985155 DOI: 10.1017/s0033291713002171] [Cited by in Crossref: 58] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
11 Blackwell J, Saxena S, Petersen I, Hotopf M, Creese H, Bottle A, Alexakis C, Pollok RC; POP-IBD study group. Depression in individuals who subsequently develop inflammatory bowel disease: a population-based nested case-control study. Gut 2021;70:1642-8. [PMID: 33109601 DOI: 10.1136/gutjnl-2020-322308] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
12 Horst S, Chao A, Rosen M, Nohl A, Duley C, Wagnon JH, Beaulieu DB, Taylor W, Gaines L, Schwartz DA. Treatment with immunosuppressive therapy may improve depressive symptoms in patients with inflammatory bowel disease. Dig Dis Sci. 2015;60:465-470. [PMID: 25274158 DOI: 10.1007/s10620-014-3375-0] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
13 Zimmerman LA, Srinath AI, Goyal A, Bousvaros A, Ducharme P, Szigethy E, Nurko S. The overlap of functional abdominal pain in pediatric Crohn's disease. Inflamm Bowel Dis. 2013;19:826-831. [PMID: 23407043 DOI: 10.1097/mib.0b013e3182802a0a] [Cited by in Crossref: 49] [Cited by in F6Publishing: 16] [Article Influence: 6.1] [Reference Citation Analysis]
14 Powell N, Walker MM, Talley NJ. The mucosal immune system: master regulator of bidirectional gut–brain communications. Nat Rev Gastroenterol Hepatol 2017;14:143-59. [DOI: 10.1038/nrgastro.2016.191] [Cited by in Crossref: 142] [Cited by in F6Publishing: 115] [Article Influence: 35.5] [Reference Citation Analysis]
15 Kim TW, Shin JS, Chung KS, Lee YG, Baek NI, Lee KT. Anti-Inflammatory Mechanisms of Koreanaside A, a Lignan Isolated from the Flower of Forsythia koreana, against LPS-Induced Macrophage Activation and DSS-Induced Colitis Mice: The Crucial Role of AP-1, NF-κB, and JAK/STAT Signaling. Cells 2019;8:E1163. [PMID: 31569788 DOI: 10.3390/cells8101163] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
16 Choi S, Woo JK, Jang YS, Kang JH, Jang JE, Yi TH, Park SY, Kim SY, Yoon YS, Oh SH. Fermented Pueraria Lobata extract ameliorates dextran sulfate sodium-induced colitis by reducing pro-inflammatory cytokines and recovering intestinal barrier function. Lab Anim Res. 2016;32:151-159. [PMID: 27729931 DOI: 10.5625/lar.2016.32.3.151] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
17 Wu Q, Zhong J. Disease-related information requirements in patients with Crohn's disease. Patient Prefer Adherence 2018;12:1579-86. [PMID: 30214160 DOI: 10.2147/PPA.S169706] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
18 Butwicka A, Olén O, Larsson H, Halfvarson J, Almqvist C, Lichtenstein P, Serlachius E, Frisén L, Ludvigsson JF. Association of Childhood-Onset Inflammatory Bowel Disease With Risk of Psychiatric Disorders and Suicide Attempt. JAMA Pediatr 2019;173:969-78. [PMID: 31424531 DOI: 10.1001/jamapediatrics.2019.2662] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
19 Ganz ML, Sugarman R, Wang R, Hansen BB, Håkan-Bloch J. The Economic and Health-related Impact of Crohn's Disease in the United States: Evidence from a Nationally Representative Survey. Inflamm Bowel Dis 2016;22:1032-41. [PMID: 26974852 DOI: 10.1097/MIB.0000000000000742] [Cited by in Crossref: 29] [Cited by in F6Publishing: 14] [Article Influence: 7.3] [Reference Citation Analysis]
20 IsHak WW, Pan D, Steiner AJ, Feldman E, Mann A, Mirocha J, Danovitch I, Melmed GY. Patient-Reported Outcomes of Quality of Life, Functioning, and GI/Psychiatric Symptom Severity in Patients with Inflammatory Bowel Disease (IBD). Inflamm Bowel Dis. 2017;23:798-803. [PMID: 28301432 DOI: 10.1097/mib.0000000000001060] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 10.7] [Reference Citation Analysis]
21 Tomazoni EI, Benvegnú DM. SYMPTOMS OF ANXIETY AND DEPRESSION, AND QUALITY OF LIFE OF PATIENTS WITH CROHN'S DISEASE. Arq Gastroenterol 2018;55:148-53. [PMID: 30043864 DOI: 10.1590/S0004-2803.201800000-26] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
22 Ohland CL, Kish L, Bell H, Thiesen A, Hotte N, Pankiv E, Madsen KL. Effects of Lactobacillus helveticus on murine behavior are dependent on diet and genotype and correlate with alterations in the gut microbiome. Psychoneuroendocrinology. 2013;38:1738-1747. [PMID: 23566632 DOI: 10.1016/j.psyneuen.2013.02.008] [Cited by in Crossref: 156] [Cited by in F6Publishing: 135] [Article Influence: 19.5] [Reference Citation Analysis]
23 Gracie DJ, Guthrie EA, Hamlin PJ, Ford AC. Bi-directionality of Brain-Gut Interactions in Patients With Inflammatory Bowel Disease. Gastroenterology. 2018;154:1635-1646.e3. [PMID: 29366841 DOI: 10.1053/j.gastro.2018.01.027] [Cited by in Crossref: 113] [Cited by in F6Publishing: 84] [Article Influence: 37.7] [Reference Citation Analysis]
24 Jackson BD, Con D, Gorelik A, Liew D, Knowles S, De Cruz P. Examination of the relationship between disease activity and patient-reported outcome measures in an inflammatory bowel disease cohort. Intern Med J 2018;48:1234-41. [PMID: 29663629 DOI: 10.1111/imj.13937] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
25 Gracie DJ, Williams CJ, Sood R, Mumtaz S, Bholah MH, Hamlin PJ, Ford AC. Poor Correlation Between Clinical Disease Activity and Mucosal Inflammation, and the Role of Psychological Comorbidity, in Inflammatory Bowel Disease. Am J Gastroenterol. 2016;111:541-551. [PMID: 27002800 DOI: 10.1038/ajg.2016.59] [Cited by in Crossref: 72] [Cited by in F6Publishing: 61] [Article Influence: 14.4] [Reference Citation Analysis]
26 Yeh AM, Wren A, Golianu B. Mind-Body Interventions for Pediatric Inflammatory Bowel Disease. Children (Basel) 2017;4:E22. [PMID: 28368365 DOI: 10.3390/children4040022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
27 Sirois FM, Hirsch JK. A longitudinal study of the profiles of psychological thriving, resilience, and loss in people with inflammatory bowel disease. Br J Health Psychol 2017;22:920-39. [DOI: 10.1111/bjhp.12262] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
28 Bhamre R, Sawrav S, Adarkar S, Sakaria R, J Bhatia S. Psychiatric comorbidities in patients with inflammatory bowel disease. Indian J Gastroenterol 2018;37:307-12. [PMID: 30196516 DOI: 10.1007/s12664-018-0870-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
29 Gareau MG. Microbiota-gut-brain axis and cognitive function. Adv Exp Med Biol 2014;817:357-71. [PMID: 24997042 DOI: 10.1007/978-1-4939-0897-4_16] [Cited by in Crossref: 85] [Cited by in F6Publishing: 64] [Article Influence: 12.1] [Reference Citation Analysis]
30 Regueiro M, Greer JB, Szigethy E. Etiology and Treatment of Pain and Psychosocial Issues in Patients with Inflammatory Bowel Diseases. Gastroenterology. 2017;152:430-439.e4. [PMID: 27816599 DOI: 10.1053/j.gastro.2016.10.036] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 10.0] [Reference Citation Analysis]
31 Trindade IA, Sirois FM. The prospective effects of self-compassion on depressive symptoms, anxiety, and stress: A study in inflammatory bowel disease. J Psychosom Res 2021;146:110429. [PMID: 33810862 DOI: 10.1016/j.jpsychores.2021.110429] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
32 Hashash JG, Ramos-Rivers C, Youk A, Chiu WK, Duff K, Regueiro M, Binion DG, Koutroubakis I, Vachon A, Benhayon D, Dunn MA, Szigethy EM. Quality of Sleep and Coexistent Psychopathology Have Significant Impact on Fatigue Burden in Patients With Inflammatory Bowel Disease. J Clin Gastroenterol 2018;52:423-30. [PMID: 27775960 DOI: 10.1097/MCG.0000000000000729] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
33 Duff W, Haskey N, Potter G, Alcorn J, Hunter P, Fowler S. Non-pharmacological therapies for inflammatory bowel disease: Recommendations for self-care and physician guidance. World J Gastroenterol 2018;24:3055-70. [PMID: 30065553 DOI: 10.3748/wjg.v24.i28.3055] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
34 Mählmann L, Gerber M, Furlano RI, Legeret C, Kalak N, Holsboer-Trachsler E, Brand S. Psychological wellbeing and physical activity in children and adolescents with inflammatory bowel disease compared to healthy controls. BMC Gastroenterol 2017;17:160. [PMID: 29233119 DOI: 10.1186/s12876-017-0721-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
35 Moran C, Sheehan D, Shanahan F. The Changing Phenotype of Inflammatory Bowel Disease. Gastroenterol Res Pract. 2016;2016:1619053. [PMID: 28050166 DOI: 10.1155/2016/1619053] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
36 Sharif K, Watad A, Coplan L, Lichtbroun B, Krosser A, Lichtbroun M, Bragazzi NL, Amital H, Afek A, Shoenfeld Y. The role of stress in the mosaic of autoimmunity: An overlooked association. Autoimmun Rev 2018;17:967-83. [PMID: 30118900 DOI: 10.1016/j.autrev.2018.04.005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 10.7] [Reference Citation Analysis]
37 Gorrepati VS, Yadav S, Stuart A, Koltun W, Messaris E, Williams ED, Coates MD. Anxiety, depression, and inflammation after restorative proctocolectomy. Int J Colorectal Dis 2018;33:1601-6. [DOI: 10.1007/s00384-018-3110-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Argyriou K, Roma E, Kapsoritakis A, Tsakiridou E, Oikonomou K, Manolakis A, Potamianos S. The Rating Form of IBD Patient Concerns: Translation, Validation, and First Implementation of the Greek Version. Gastroenterol Res Pract 2017;2017:6267175. [PMID: 28529522 DOI: 10.1155/2017/6267175] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Farmer AD, Randall HA, Aziz Q. It's a gut feeling: how the gut microbiota affects the state of mind. J Physiol 2014;592:2981-8. [PMID: 24665099 DOI: 10.1113/jphysiol.2013.270389] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
40 Hunt MG, Loftus P, Accardo M, Keenan M, Cohen L, Osterman MT. Self-help Cognitive Behavioral Therapy Improves Health-Related Quality of Life for Inflammatory Bowel Disease Patients: A Randomized Controlled Effectiveness Trial. J Clin Psychol Med Settings 2020;27:467-79. [PMID: 31025253 DOI: 10.1007/s10880-019-09621-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
41 Abautret-Daly Á, Dempsey E, Parra-Blanco A, Medina C, Harkin A. Gut-brain actions underlying comorbid anxiety and depression associated with inflammatory bowel disease. Acta Neuropsychiatr 2018;30:275-96. [PMID: 28270247 DOI: 10.1017/neu.2017.3] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 13.0] [Reference Citation Analysis]
42 Van Assche G, Peyrin-Biroulet L, Sturm A, Gisbert JP, Gaya DR, Bokemeyer B, Mantzaris GJ, Armuzzi A, Sebastian S, Lara N, Lynam M, Rojas-Farreras S, Fan T, Ding Q, Black CM, Kachroo S. Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months - Multicenter European cohort study. Dig Liver Dis. 2016;48:592-600. [PMID: 26935454 DOI: 10.1016/j.dld.2016.01.011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
43 Wang G, Huang S, Wang Y, Cai S, Yu H, Liu H, Zeng X, Zhang G, Qiao S. Bridging intestinal immunity and gut microbiota by metabolites. Cell Mol Life Sci 2019;76:3917-37. [PMID: 31250035 DOI: 10.1007/s00018-019-03190-6] [Cited by in Crossref: 57] [Cited by in F6Publishing: 45] [Article Influence: 28.5] [Reference Citation Analysis]
44 Wilkinson B, Trick L, Knight A, Valton V, Goodhand J, Kennedy NA, Heerasing N, Ahmad T, Bland A, Elliott R, Roiser JP, Dickens C. Factors associated with depression in people with inflammatory bowel disease: The relationship between active disease and biases in neurocognitive processing. Neurogastroenterol Motil 2019;31:e13647. [PMID: 31267614 DOI: 10.1111/nmo.13647] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
45 Odes S, Friger M, Sergienko R, Schwartz D, Sarid O, Slonim-Nevo V, Singer T, Chernin E, Vardi H, Greenberg D, Israel Ibd Research Nucleus. Simple pain measures reveal psycho-social pathology in patients with Crohn's disease. World J Gastroenterol 2017;23:1076-89. [PMID: 28246482 DOI: 10.3748/wjg.v23.i6.1076] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
46 Yongwen Ng J, Chauhan U, Armstrong D, Marshall J, Tse F, Moayyedi P, Reinisch W, Halder S. A Comparison of the Prevalence of Anxiety and Depression Between Uncomplicated and Complex IBD Patient Groups: . Gastroenterology Nursing 2018;41:427-35. [DOI: 10.1097/sga.0000000000000338] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
47 Segal JP, Htet HMT, Limdi J, Hayee B. How to manage IBD in the 'elderly'. Frontline Gastroenterol 2020;11:468-77. [PMID: 33101625 DOI: 10.1136/flgastro-2019-101218] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Feuerstein JD, Moss AC, Farraye FA. Ulcerative Colitis. Mayo Clin Proc. 2019;94:1357-1373. [PMID: 31272578 DOI: 10.1016/j.mayocp.2019.01.018] [Cited by in Crossref: 54] [Cited by in F6Publishing: 35] [Article Influence: 54.0] [Reference Citation Analysis]
49 Coates MD, Lahoti M, Binion DG, Szigethy EM, Regueiro MD, Bielefeldt K. Abdominal pain in ulcerative colitis. Inflamm Bowel Dis 2013;19:2207-14. [PMID: 23929261 DOI: 10.1097/MIB.0b013e31829614c6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 3.4] [Reference Citation Analysis]
50 Calloway A, Dalal R, Beaulieu DB, Duley C, Annis K, Gaines L, Slaughter C, Schwartz DA, Horst S. Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease. Dig Dis Sci 2017;62:3563-7. [PMID: 29052816 DOI: 10.1007/s10620-017-4800-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 4.8] [Reference Citation Analysis]
51 Campos S, Portela F, Sousa P, Sofia C. Inflammatory bowel disease: adherence to immunomodulators in a biological therapy era. Eur J Gastroenterol Hepatol 2016;28:1313-9. [PMID: 27501126 DOI: 10.1097/MEG.0000000000000704] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
52 Brzozowski B, Mazur-Bialy A, Pajdo R, Kwiecien S, Bilski J, Zwolinska-Wcislo M, Mach T, Brzozowski T. Mechanisms by which Stress Affects the Experimental and Clinical Inflammatory Bowel Disease (IBD): Role of Brain-Gut Axis. Curr Neuropharmacol. 2016;14:892-900. [PMID: 27040468 DOI: 10.2174/1570159x14666160404124127] [Cited by in Crossref: 58] [Cited by in F6Publishing: 24] [Article Influence: 14.5] [Reference Citation Analysis]
53 Byrne G, Rosenfeld G, Leung Y, Qian H, Raudzus J, Nunez C, Bressler B. Prevalence of Anxiety and Depression in Patients with Inflammatory Bowel Disease. Can J Gastroenterol Hepatol 2017;2017:6496727. [PMID: 29181373 DOI: 10.1155/2017/6496727] [Cited by in Crossref: 73] [Cited by in F6Publishing: 60] [Article Influence: 18.3] [Reference Citation Analysis]
54 van den Brink G, Stapersma L, Vlug LE, Rizopolous D, Bodelier AG, van Wering H, Hurkmans PCWM, Stuyt RJL, Hendriks DM, van der Burg JAT, Utens EMWJ, Escher JC. Clinical disease activity is associated with anxiety and depressive symptoms in adolescents and young adults with inflammatory bowel disease. Aliment Pharmacol Ther 2018;48:358-69. [PMID: 29897134 DOI: 10.1111/apt.14832] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
55 Kim MC, Jung YS, Song YS, Lee JI, Park JH, Sohn CI, Choi KY, Park DI. Factors Associated with Anxiety and Depression in Korean Patients with Inactive Inflammatory Bowel Disease. Gut Liver 2016;10:399-405. [PMID: 26470768 DOI: 10.5009/gnl15188] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
56 Elbay RY, Karatepe HT, Ulaşoğlu C, Görmez A. Relation of Repetitive Thinking Styles with Anxiety and Depression in Patients with Inflammatory Bowel Disease. J Clin Psychol Med Settings 2021. [PMID: 33905081 DOI: 10.1007/s10880-021-09780-6] [Reference Citation Analysis]
57 Rampton DS, Goodhand JR, Joshi NM, Karim AB, Koodun Y, Barakat FM, Macken L, Ward DG, Iqbal TH, Epstein J, Fell JM, Sanderson IR. Oral Iron Treatment Response and Predictors in Anaemic Adolescents and Adults with IBD: A Prospective Controlled Open-Label Trial. J Crohns Colitis 2017;11:706-15. [PMID: 27932449 DOI: 10.1093/ecco-jcc/jjw208] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
58 Zhang M, Hong L, Zhang T, Lin Y, Zheng S, Zhou X, Fan R, Wang Z, Zhang C, Zhong J. Illness perceptions and stress: mediators between disease severity and psychological well-being and quality of life among patients with Crohn's disease. Patient Prefer Adherence 2016;10:2387-96. [PMID: 27920505 DOI: 10.2147/PPA.S118413] [Cited by in Crossref: 29] [Cited by in F6Publishing: 8] [Article Influence: 5.8] [Reference Citation Analysis]
59 Hall BJ, Hamlin PJ, Gracie DJ, Ford AC. The Effect of Antidepressants on the Course of Inflammatory Bowel Disease. Can J Gastroenterol Hepatol 2018;2018:2047242. [PMID: 30271765 DOI: 10.1155/2018/2047242] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
60 Hwang JH, Yu CS. Depression and resilience in ulcerative colitis and Crohn's disease patients with ostomy. Int Wound J 2019;16 Suppl 1:62-70. [PMID: 30793856 DOI: 10.1111/iwj.13076] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
61 Lasconi C, Pahl MC, Cousminer DL, Doege CA, Chesi A, Hodge KM, Leonard ME, Lu S, Johnson ME, Su C, Hammond RK, Pippin JA, Terry NA, Ghanem LR, Leibel RL, Wells AD, Grant SFA. Variant-to-Gene-Mapping Analyses Reveal a Role for the Hypothalamus in Genetic Susceptibility to Inflammatory Bowel Disease. Cell Mol Gastroenterol Hepatol 2021;11:667-82. [PMID: 33069917 DOI: 10.1016/j.jcmgh.2020.10.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
62 Marin IA, Goertz JE, Ren T, Rich SS, Onengut-Gumuscu S, Farber E, Wu M, Overall CC, Kipnis J, Gaultier A. Microbiota alteration is associated with the development of stress-induced despair behavior. Sci Rep 2017;7:43859. [PMID: 28266612 DOI: 10.1038/srep43859] [Cited by in Crossref: 136] [Cited by in F6Publishing: 120] [Article Influence: 34.0] [Reference Citation Analysis]
63 Niccolai E, Boem F, Russo E, Amedei A. The Gut⁻Brain Axis in the Neuropsychological Disease Model of Obesity: A Classical Movie Revised by the Emerging Director "Microbiome". Nutrients 2019;11:E156. [PMID: 30642052 DOI: 10.3390/nu11010156] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 13.0] [Reference Citation Analysis]
64 Calixto RP, Flores C, Francesconi CF. Inflammatory bowel disease: impact on scores of quality of life, depression and anxiety in patients attending a tertiary care center in brazil. Arq Gastroenterol. 2018;55:202-207. [PMID: 30540078 DOI: 10.1590/s0004-2803.201800000-54] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
65 Szigethy EM, Youk AO, Benhayon D, Fairclough DL, Newara MC, Kirshner MA, Bujoreanu SI, Mrakotsky C, Bousvaros A, Srinath AI, Keljo DJ, Kupfer DJ, DeMaso DR. Depression subtypes in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2014;58:574-581. [PMID: 24345836 DOI: 10.1097/mpg.0000000000000262] [Cited by in Crossref: 39] [Cited by in F6Publishing: 17] [Article Influence: 5.6] [Reference Citation Analysis]
66 Cordaro M, Scuto M, Siracusa R, D'amico R, Filippo Peritore A, Gugliandolo E, Fusco R, Crupi R, Impellizzeri D, Pozzebon M, Alfonsi D, Mattei N, Marcolongo G, Evangelista M, Cuzzocrea S, Di Paola R. Effect of N-palmitoylethanolamine-oxazoline on comorbid neuropsychiatric disturbance associated with inflammatory bowel disease. FASEB J 2020;34:4085-106. [PMID: 31950563 DOI: 10.1096/fj.201901584RR] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
67 Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease. Am J Gastroenterol. 2017;112:241-258. [PMID: 28071656 DOI: 10.1038/ajg.2016.537] [Cited by in Crossref: 218] [Cited by in F6Publishing: 150] [Article Influence: 54.5] [Reference Citation Analysis]
68 Jordan C, Sin J, Fear NT, Chalder T. A systematic review of the psychological correlates of adjustment outcomes in adults with inflammatory bowel disease. Clin Psychol Rev. 2016;47:28-40. [PMID: 27318795 DOI: 10.1016/j.cpr.2016.06.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 5.6] [Reference Citation Analysis]
69 Coates MD, Seth N, Clarke K, Abdul-Baki H, Mahoney N, Walter V, Regueiro MD, Ramos-Rivers C, Koutroubakis IE, Bielefeldt K, Binion DG. Opioid Analgesics Do Not Improve Abdominal Pain or Quality of Life in Crohn's Disease. Dig Dis Sci 2020;65:2379-87. [PMID: 31758431 DOI: 10.1007/s10620-019-05968-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
70 Nazarian A, Bishay K, Gholami R, Scaffidi MA, Khan R, Cohen-Lyons D, Griller N, Satchwell JB, Baker JP, Grover SC, Irvine EJ. Factors Associated with Poor Quality of Life in a Canadian Cohort of Patients with Inflammatory Bowel Disease: A Cross-sectional Study. J Can Assoc Gastroenterol 2021;4:91-6. [PMID: 33855267 DOI: 10.1093/jcag/gwaa014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Martino G, Caputo A, Schwarz P, Bellone F, Fries W, Quattropani MC, Vicario CM. Alexithymia and Inflammatory Bowel Disease: A Systematic Review. Front Psychol 2020;11:1763. [PMID: 32973596 DOI: 10.3389/fpsyg.2020.01763] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 19.0] [Reference Citation Analysis]
72 Tarricone I, Regazzi MG, Bonucci G, Rizzello F, Carini G, Muratori R, Poggioli G, Campieri M. Prevalence and effectiveness of psychiatric treatments for patients with IBD: A systematic literature review. Journal of Psychosomatic Research 2017;101:68-95. [DOI: 10.1016/j.jpsychores.2017.07.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
73 Thorkelson G, Bielefeldt K, Szigethy E. Empirically Supported Use of Psychiatric Medications in Adolescents and Adults with IBD: . Inflammatory Bowel Diseases 2016;22:1509-22. [DOI: 10.1097/mib.0000000000000734] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 3.4] [Reference Citation Analysis]
74 Winston JH, Sarna SK. Enhanced sympathetic nerve activity induced by neonatal colon inflammation induces gastric hypersensitivity and anxiety-like behavior in adult rats. Am J Physiol Gastrointest Liver Physiol 2016;311:G32-9. [PMID: 27151940 DOI: 10.1152/ajpgi.00067.2016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
75 Chen J, Winston JH, Fu Y, Guptarak J, Jensen KL, Shi XZ, Green TA, Sarna SK. Genesis of anxiety, depression, and ongoing abdominal discomfort in ulcerative colitis-like colon inflammation. Am J Physiol Regul Integr Comp Physiol 2015;308:R18-27. [PMID: 25411361 DOI: 10.1152/ajpregu.00298.2014] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
76 Mikocka-Walus A, Knowles SR, Keefer L, Graff L. Controversies Revisited: A Systematic Review of the Comorbidity of Depression and Anxiety with Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2016;22:752-762. [PMID: 26841224 DOI: 10.1097/mib.0000000000000620] [Cited by in Crossref: 225] [Cited by in F6Publishing: 79] [Article Influence: 45.0] [Reference Citation Analysis]
77 Nyuyki KD, Cluny NL, Swain MG, Sharkey KA, Pittman QJ. Altered Brain Excitability and Increased Anxiety in Mice With Experimental Colitis: Consideration of Hyperalgesia and Sex Differences. Front Behav Neurosci 2018;12:58. [PMID: 29670513 DOI: 10.3389/fnbeh.2018.00058] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
78 Sweeney L, Moss-morris R, Czuber-dochan W, Meade L, Chumbley G, Norton C. Systematic review: psychosocial factors associated with pain in inflammatory bowel disease. Aliment Pharmacol Ther 2018;47:715-29. [DOI: 10.1111/apt.14493] [Cited by in Crossref: 38] [Cited by in F6Publishing: 26] [Article Influence: 12.7] [Reference Citation Analysis]
79 Yalcin I, Barrot M. The anxiodepressive comorbidity in chronic pain. Current Opinion in Anaesthesiology 2014;27:520-7. [DOI: 10.1097/aco.0000000000000116] [Cited by in Crossref: 52] [Cited by in F6Publishing: 22] [Article Influence: 7.4] [Reference Citation Analysis]
80 Deberry JJ, Bielefeldt K, Davis BM, Szigethy EM, Hartman DJ, Coates MD. Abdominal pain and the neurotrophic system in ulcerative colitis. Inflamm Bowel Dis. 2014;20:2330-2339. [PMID: 25358061 DOI: 10.1097/mib.0000000000000207] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]
81 Traina G. Mast Cells in Gut and Brain and Their Potential Role as an Emerging Therapeutic Target for Neural Diseases. Front Cell Neurosci 2019;13:345. [PMID: 31417365 DOI: 10.3389/fncel.2019.00345] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 9.5] [Reference Citation Analysis]
82 Reichmann F, Hassan AM, Farzi A, Jain P, Schuligoi R, Holzer P. Dextran sulfate sodium-induced colitis alters stress-associated behaviour and neuropeptide gene expression in the amygdala-hippocampus network of mice. Sci Rep 2015;5:9970. [PMID: 26066467 DOI: 10.1038/srep09970] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 5.5] [Reference Citation Analysis]
83 Keeton RL, Mikocka-Walus A, Andrews JM. Concerns and worries in people living with inflammatory bowel disease (IBD): A mixed methods study. J Psychosom Res. 2015;78:573-578. [PMID: 25543858 DOI: 10.1016/j.jpsychores.2014.12.004] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 4.9] [Reference Citation Analysis]
84 Wang H, Tu L, Li Y, Bai T, Zou K, Xiao F, Li J, Chen M, Zhang H, Li G, Lu Y, Wang K, Jin S, Yang Y, Zhu L, Hou X. The Symptoms and Medications of Patients with Inflammatory Bowel Disease in Hubei Province after COVID-19 Epidemic. J Immunol Res. 2020;2020:2847316. [PMID: 33062719 DOI: 10.1155/2020/2847316] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
85 Bernabeu P, van-der Hofstadt C, Rodríguez-Marín J, Gutierrez A, Alonso MR, Zapater P, Jover R, Sempere L. Effectiveness of a Multicomponent Group Psychological Intervention Program in Patients with Inflammatory Bowel Disease: A Randomized Trial. Int J Environ Res Public Health 2021;18:5439. [PMID: 34069621 DOI: 10.3390/ijerph18105439] [Reference Citation Analysis]
86 Erős A, Soós A, Hegyi P, Szakács Z, Erőss B, Párniczky A, Mezősi E, Rumbus Z, Sarlós P. Spotlight on Transition in Patients With Inflammatory Bowel Disease: A Systematic Review. Inflamm Bowel Dis 2020;26:331-46. [PMID: 31504524 DOI: 10.1093/ibd/izz173] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
87 Bannaga AS, Selinger CP. Inflammatory bowel disease and anxiety: links, risks, and challenges faced. Clin Exp Gastroenterol 2015;8:111-7. [PMID: 25848313 DOI: 10.2147/CEG.S57982] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
88 Wardle RA, Wardle AJ, Charadva C, Ghosh S, Moran GW. Literature review: impacts of socioeconomic status on the risk of inflammatory bowel disease and its outcomes. European Journal of Gastroenterology & Hepatology 2017;29:879-84. [DOI: 10.1097/meg.0000000000000899] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
89 van den Brink G, Stapersma L, El Marroun H, Henrichs J, Szigethy EM, Utens EM, Escher JC. Effectiveness of disease-specific cognitive-behavioural therapy on depression, anxiety, quality of life and the clinical course of disease in adolescents with inflammatory bowel disease: study protocol of a multicentre randomised controlled trial (HAPPY-IBD). BMJ Open Gastroenterol 2016;3:e000071. [PMID: 26966551 DOI: 10.1136/bmjgast-2015-000071] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
90 Lv WJ, Liu C, Yu LZ, Zhou JH, Li Y, Xiong Y, Guo A, Chao LM, Qu Q, Wei GW, Tang XG, Yin YL, Guo SN. Melatonin Alleviates Neuroinflammation and Metabolic Disorder in DSS-Induced Depression Rats. Oxid Med Cell Longev 2020;2020:1241894. [PMID: 32802257 DOI: 10.1155/2020/1241894] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
91 Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. ACG Clinical Guideline: Management of Crohn's Disease in Adults. Am J Gastroenterol. 2018;113:481-517. [PMID: 29610508 DOI: 10.1038/ajg.2018.27] [Cited by in Crossref: 390] [Cited by in F6Publishing: 277] [Article Influence: 130.0] [Reference Citation Analysis]
92 Navabi S, Gorrepati VS, Yadav S, Chintanaboina J, Maher S, Demuth P, Stern B, Stuart A, Tinsley A, Clarke K, Williams ED, Coates MD. Influences and Impact of Anxiety and Depression in the Setting of Inflammatory Bowel Disease. Inflamm Bowel Dis 2018;24:2303-8. [PMID: 29788469 DOI: 10.1093/ibd/izy143] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 18.5] [Reference Citation Analysis]
93 Legaki E, Gazouli M. Influence of environmental factors in the development of inflammatory bowel diseases. World J Gastrointest Pharmacol Ther. 2016;7:112-125. [PMID: 26855817 DOI: 10.4292/wjgpt.v7.i1.112] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 41] [Article Influence: 9.4] [Reference Citation Analysis]
94 Szigethy E, Youk AO, Gonzalez-Heydrich J, Bujoreanu SI, Weisz J, Fairclough D, Ducharme P, Jones N, Lotrich F, Keljo D. Effect of 2 psychotherapies on depression and disease activity in pediatric Crohn's disease. Inflamm Bowel Dis. 2015;21:1321-1328. [PMID: 25822010 DOI: 10.1097/mib.0000000000000358] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
95 Mikocka-walus AA, Gordon AL, Stewart BJ, Andrews JM. ‘ Just to get it off my chest ’: Patients' views on psychotherapy in inflammatory bowel disease. Counselling and Psychotherapy Research 2013;13:227-34. [DOI: 10.1080/14733145.2012.730540] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
96 Holzer P, Farzi A, Hassan AM, Zenz G, Jačan A, Reichmann F. Visceral Inflammation and Immune Activation Stress the Brain. Front Immunol 2017;8:1613. [PMID: 29213271 DOI: 10.3389/fimmu.2017.01613] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 7.5] [Reference Citation Analysis]
97 Vidal de Lima FD, da Rocha Ribeiro TC, Andrade Chebli L, de Lima Pace FH, de Miranda Chaves LD, Sérgio Ribeiro M, Fonseca Chebli JM. Mood swings in patients with Crohn's disease: incidence and associated factors. Revista da Associação Médica Brasileira 2012;58:481-8. [DOI: 10.1016/s0104-4230(12)70233-6] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
98 Triantafillidis JK, Merikas E, Gikas A. Psychological factors and stress in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2013;7:225-238. [PMID: 23445232 DOI: 10.1586/egh.13.4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
99 Schreiner P, Biedermann L, Rossel JB, Rogler G, Pittet V, von Känel R; Swiss IBD Cohort Study Group. Prevalence and Determinants of Job Stress in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis 2017;23:310-7. [PMID: 28079622 DOI: 10.1097/MIB.0000000000001012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015;12:205-217. [PMID: 25732745 DOI: 10.1038/nrgastro.2015.34] [Cited by in Crossref: 662] [Cited by in F6Publishing: 560] [Article Influence: 110.3] [Reference Citation Analysis]
101 Srinath A, Young E, Szigethy E. Pain management in patients with inflammatory bowel disease: translational approaches from bench to bedside. Inflamm Bowel Dis 2014;20:2433-49. [PMID: 25208108 DOI: 10.1097/MIB.0000000000000170] [Cited by in Crossref: 45] [Cited by in F6Publishing: 21] [Article Influence: 7.5] [Reference Citation Analysis]
102 Williet N, Sandborn WJ, Peyrin-Biroulet L. Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease. Clin Gastroenterol Hepatol. 2014;12:1246-1256.e6. [PMID: 24534550 DOI: 10.1016/j.cgh.2014.02.016] [Cited by in Crossref: 153] [Cited by in F6Publishing: 125] [Article Influence: 21.9] [Reference Citation Analysis]
103 Li Y, Zhu W, Zuo L, Shen B. The Role of the Mesentery in Crohnʼs Disease: The Contributions of Nerves, Vessels, Lymphatics, and Fat to the Pathogenesis and Disease Course. Inflammatory Bowel Diseases 2016;22:1483-95. [DOI: 10.1097/mib.0000000000000791] [Cited by in Crossref: 43] [Cited by in F6Publishing: 10] [Article Influence: 8.6] [Reference Citation Analysis]
104 Ananthakrishnan AN, Khalili H, Pan A, Higuchi LM, de Silva P, Richter JM, Fuchs CS, Chan AT. Association between depressive symptoms and incidence of Crohn's disease and ulcerative colitis: results from the Nurses' Health Study. Clin Gastroenterol Hepatol. 2013;11:57-62. [PMID: 22944733 DOI: 10.1016/j.cgh.2012.08.032] [Cited by in Crossref: 77] [Cited by in F6Publishing: 65] [Article Influence: 8.6] [Reference Citation Analysis]
105 Coates MD, Johri A, Gorrepati VS, Maheshwari P, Dalessio S, Walter V, Stuart A, Koltun W, Bernasko N, Tinsley A, Williams ED, Clarke K. Abdominal pain in quiescent inflammatory bowel disease. Int J Colorectal Dis 2021;36:93-102. [PMID: 32879990 DOI: 10.1007/s00384-020-03727-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Alexakis C, Kumar S, Saxena S, Pollok R. Systematic review with meta-analysis: the impact of a depressive state on disease course in adult inflammatory bowel disease. Aliment Pharmacol Ther 2017;46:225-35. [DOI: 10.1111/apt.14171] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 6.5] [Reference Citation Analysis]